Is Cold Exposure a Viable Lifestyle Intervention for Mental Health? Reviewing Evidence and Mechanisms

• Cold water immersion (CWI): submerging the body in cold water (roughly 1–15°C) for a few minutes

• Whole-body cryotherapy (WBC): brief exposure to extremely cold air (below −73°C) in a specialized chamber

• Catecholamines: a group of stress-related brain chemicals/hormones (norepinephrine, dopamine, epinephrine) involved in mood, alertness, and the fight-or-flight response

• HPA axis (hypothalamic-pituitary-adrenal axis): the body's central stress-response system that ultimately triggers cortisol release Cortisol — the body's primary stress hormone

• Thermoreceptors (TRPM8/TRPA1): specialized nerve receptors in the skin that detect cold temperatures

• Locus coeruleus (LC): a brain region that is the main source of norepinephrine in the brain, involved in alertness and arousal

• Pro-inflammatory cytokines (IL-6, TNF-α): signaling molecules released by the immune system during inflammation, linked to depression and anxiety when chronically elevated

• Randomized controlled trial (RCT): a study design where participants are randomly assigned to a treatment or control group, considered the gold standard for testing whether a treatment works

• Habituation: the body's tendency to respond less strongly to a repeated stimulus over time

• Placebo/expectancy effect: improvement that occurs because a person expects or believes a treatment will help, independent of the treatment's actual physiological effect

1. What is the current empirical evidence (from RCTs, observational studies, and translational (animal/lab) research) for cold exposure improving mood, depression, anxiety, and stress-related symptoms

2. What physiological mechanisms (catecholamine signaling, HPA-axis/cortisol regulation, and inflammatory/immune pathways) might explain any such effects, and how well-supported are these mechanisms by existing data.

Acute mood effects (healthy individuals): Only three trials exist. Brief cold water immersion produced small but significant short-term mood improvements (increased vigor, decreased tension, and increased positive affect) compared to non-active controls. One trial linked mood improvement to increased connectivity between brain networks involved in salience and attention. All three trials had small samples (16–42 participants), self-selected volunteers, and no active control conditions.

Clinical populations: Only three RCTs have tested cold exposure in people with diagnosed depression/anxiety. Two whole-body cryotherapy trials found significantly greater reductions in depression and anxiety scores versus waitlist or sham controls, though one had unbalanced baseline scores and the other's benefit faded by two-week follow-up. A third trial testing cold showers combined with "Wim Hof" breathing found reductions in depression and anxiety, but these were no different from a warm-shower/slow-breathing control group; meaning the specific contribution of cold exposure itself couldn't be isolated.

Mechanisms: Catecholamines: Cold exposure reliably and robustly raises peripheral norepinephrine (up to 5-fold), an effect that persists with repeated exposure (unlike cortisol, which habituates). However, whether peripheral norepinephrine increases reflect meaningful central (brain) catecholamine activity relevant to mood remains unproven in humans.

HPA axis/cortisol: Cold exposure triggers acute cortisol release, but repeated exposure blunts this response over time (habituation). Notably, cortisol often peaks before immersion even occurs, suggesting psychological anticipation (not just physiological cold exposure) drives part of the stress response. No human trial has yet linked cortisol changes to actual psychiatric improvement.

Inflammation/immune function: Findings are inconsistent — some studies show anti-inflammatory shifts with habitual cold exposure, others show increased inflammatory markers after single sessions, and studies that found mood benefits from cryotherapy found no corresponding change in inflammatory markers (IL-6, CRP, IL-10).

The authors conclude that while cold exposure has clear, measurable acute physiological effects (catecholamine surges, transient cortisol elevation, immune cell shifts), the link between these biological changes and actual mental health benefit remains unproven — psychological improvements have not been reliably tied to the proposed biological mechanisms.

They emphasize that some benefit may come from non-physiological factors like a sense of self-efficacy or mastery from voluntarily enduring discomfort, rather than the cold itself.

Key recommendations for future research include: using standardized protocols (temperature, duration, frequency) to allow studies to be pooled and compared; including active/credible sham control conditions (e.g., comfortably cool rather than truly cold water) to separate specific cold effects from placebo/expectancy effects, using tools like the Credibility/Expectancy Questionnaire; recruiting adequately powered clinical samples with standardized psychiatric outcome measures (HAM-D, BDI); tracking the durability of any benefits over time, not just immediate post-exposure changes; and expanding research beyond depression to conditions with strong somatic components, such as panic disorder and chronic pain.

The authors also flag safety concerns: cold exposure carries risk of arrhythmia and hypothermia, and is contraindicated in people with coronary artery disease, asthma, spinal cord injury, autonomic dysfunction, or Raynaud's disease; populations who should only attempt it under medical supervision. Overall, they frame cold exposure as a "promising, yet still unproven" adjunct for mood regulation rather than an established treatment.